Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
| Fund/benchmark | Change | |
|---|---|---|
| Price | The Biotech Growth Trust PLC (Ordinary Share) | +34.05% |
| NAV | The Biotech Growth Trust PLC (Ordinary Share) | +25.63% |
| Morningstar's Benchmark | NASDAQ Biotechnology TR GBP | +27.46% |
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Total Voting Rights
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
More ▼
Key statistics
On Friday, The Biotech Growth Trust PLC (BIOG:LSE) closed at 1,195.00, -8.08% below its 52-week high of 1,300.00, set on Jan 23, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Shares outstanding | 20.75m |
|---|---|
| Market cap | 251.05m GBP |
| Total assets | 286.82m GBP |
| Total expense ratio | -- |
| High | 1,210.00 |
| Low | 1,175.00 |
| Previous close | 1,210.00 |
| Average volume | 59.34k |
|---|---|
| YTD Change | -0.42% |
| Beta | 0.6200 |
| Diluted NAV (est) | 1,297.07 |
| Diluted NAV (last pub) | 1,254.50 |
| Premium/Discount | -5.54% |
| Net Gearing | +8.64% |
Data delayed at least 20 minutes, as of Feb 06 2026 16:38 GMT.
More ▼


